- Vouliez-vous dire
- sans-cov-2
Résultats de la recherche - 200 results
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Studies Health Personnel Humans Immunoglobulin G Immunoglobulin M incidence Male prevalence Prospective Studies SARS-CoV-2 Seroepidemiologic Studies Abstract: OBJECTIVES: To estimate the prevalence, ...
SARS-CoV-2 Surveillance in Belgian Wastewaters
Correlation public health authority SARS-CoV-2 Surveillance viral load per capita viral to faecal ratio wastewater-based epidemiology Abstract: Wastewater-based surveillance was conducted by the national public ...
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.
SARS-CoV-2 Treatment Outcome Abstract: OBJECTIVES: This study aimed to assess the efficacy and safety of 300 mg camostat mesylate three times daily in a fasted state to treat early phase COVID-19 in an ...
Hepatitis of unknown aetiology in children- epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.
Euro Surveill, Volume 27, Issue 31 (2022) Keywords: Child COVID-19 Europe Hepatitis A Hospitalization Humans SARS-CoV-2 Abstract: Following the report of an excess in paediatric cases of severe acute ...
Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021.
8 (2022) Keywords: Belgium COVID-19 Humans SARS-CoV-2 Vaccination Abstract: We investigated the serial interval for SARS-CoV-2 Omicron BA.1 and Delta variants and observed a shorter serial interval for ...
Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium.
Humans SARS-CoV-2 Abstract: INTRODUCTION: The pathogenesis of COVID-19 depends on the interplay between host characteristics, viral characteristics and contextual factors. Here, we compare COVID-19 disease ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
RNA, Messenger SARS-CoV-2 Vaccination Vaccines, Synthetic Abstract: It is critical to protect immunocompromised patients against COVID-19 with effective SARS-CoV-2 vaccination as they have an increased ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
cancer, especially hematological cancer, are at increased risk for breakthrough COVID-19 infection. So far, a predictive biomarker that can assess compromised vaccine-induced anti- SARS-CoV-2 immunity in ...
Was SARI surveillance successful at monitoring SARS-CoV-2 circulation and its genomic evolution in Belgium throughout the pandemic?
Publication Type: Scientific poster, presentation or proceeding Authors: Sarah Denayer; Bert Monsieurs; Reinout Van Eycken; Marijke Reynders; Evelyn Petit; Koen Magerman; Door Jouck; Marieke Bleyen; Nicolas Dauby; Marc Hainaut; Lucie Seyler; Thomas Demuys ...
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
Weyenbergh; Lucy Catteau; Simon Dellicour Source: Viruses, Volume 14, Issue 6 (2022) Keywords: Aged Belgium COVID-19 COVID-19 Vaccines Hospitalization Humans SARS-CoV-2 Vaccination Abstract: The national ...